| A First In Human Study Of PF-00184562 In Healthy Volunteers (NCT00150215) | Pfizer | 2005-07-01 |
| US Inhaled Insulin Therapeutic Choice Questionnaire Study (NCT00139763) | Pfizer | 2005-07-01 |
| Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma (NCT00130897) | Pfizer | 2005-07-01 |
| Nasopharyngeal Streptococcus Pneumoniae Carriage (NCT00471822) | Pfizer | 2005-07-01 |
| An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend (NCT00150319) | Pfizer | 2005-06-01 |
| Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia (NCT00174382) | Pfizer | 2005-06-01 |
| Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children (NCT00163618) | Pfizer | 2005-06-01 |
| Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225) (NCT00163540) | Pfizer | 2005-05-01 |
| A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients (NCT00106639) | Pfizer | 2005-05-01 |
| Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) (NCT00117598) | Pfizer | 2005-05-01 |
| Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer (NCT00137423) | Pfizer | 2005-05-01 |
| The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease (NCT00163085) | Pfizer | 2005-05-01 |
| TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209) (NCT00161967) | Pfizer | 2005-05-01 |
| A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together (NCT00618124) | Pfizer | 2005-05-01 |
| Co-Administration Of Methotrexate And CP-690,550 (NCT01745055) | Pfizer | 2005-04-01 |
| Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer (NCT00143390) | Pfizer | 2005-04-01 |
| Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis (NCT00227240) | Pfizer | 2005-04-01 |
| A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control (NCT00134147) | Pfizer | 2005-04-01 |
| Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy (NCT00136968) | Pfizer | 2005-04-01 |
| A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer (NCT00102895) | Pfizer | 2005-04-01 |
| Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder (NCT00143091) | Pfizer | 2005-04-01 |
| A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer (NCT00649090) | Pfizer | 2005-03-01 |
| Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate (NCT00139061) | Pfizer | 2005-03-01 |
| A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors (NCT00615446) | Pfizer | 2005-03-01 |
| CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies (NCT01653158) | Pfizer | 2005-03-01 |
| A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects (NCT00134199) | Pfizer | 2005-03-01 |
| A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade (NCT00174512) | Pfizer | 2005-03-01 |
| Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. (NCT00145431) | Pfizer | 2005-03-01 |
| Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia (NCT00134485) | Pfizer | 2005-03-01 |
| A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics (NCT00150397) | Pfizer | 2005-03-01 |
| Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors (NCT00106353) | Pfizer | 2005-03-01 |
| Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder (NCT00134511) | Pfizer | 2005-03-01 |
| Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer (NCT00094094) | Pfizer | 2005-02-01 |
| A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation (NCT00141167) | Pfizer | 2005-02-01 |
| Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction (NCT00174486) | Pfizer | 2005-02-01 |
| A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides (NCT00134498) | Pfizer | 2005-02-01 |
| Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (NCT00143312) | Pfizer | 2005-02-01 |
| Use of 852A in Metastatic Cutaneous Melanoma. (NCT00189332) | Pfizer | 2005-02-01 |
| Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age (NCT00174252) | Pfizer | 2005-02-01 |
| Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction (NCT00141349) | Pfizer | 2005-02-01 |
| Donepezil in the Prevention of Post-Operative Cognitive Decline (NCT00182845) | Pfizer | 2005-02-01 |
| Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy (NCT00303186) | Pfizer | 2005-02-01 |
| Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer (NCT00147537) | Pfizer | 2005-02-01 |
| A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) (NCT00457743) | Pfizer | 2005-01-01 |
| Growth Retardation In Children With Special Pathological Conditions Or Disease (NCT00163215) | Pfizer | 2005-01-01 |
| Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks (NCT00147498) | Pfizer | 2005-01-01 |
| Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients (NCT00150345) | Pfizer | 2005-01-01 |
| Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer (NCT00092001) | Pfizer | 2005-01-01 |
| Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation (NCT00219635) | Pfizer | 2005-01-01 |
| Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm (NCT00163189) | Pfizer | 2005-01-01 |
| Dalacin-T Gel Post Approval Study (NCT00219570) | Pfizer | 2005-01-01 |
| An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation (NCT00143325) | Pfizer | 2005-01-01 |
| Assessment Of Safety Of UK-390,957 (NCT00219609) | Pfizer | 2005-01-01 |
| A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD (NCT00163098) | Pfizer | 2004-12-01 |
| Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma (NCT00094107) | Pfizer | 2004-12-01 |
| 12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation (NCT00139750) | Pfizer | 2004-12-01 |
| To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. (NCT00143104) | Pfizer | 2004-12-01 |
| SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma (NCT00089648) | Pfizer | 2004-12-01 |
| Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone (NCT00174200) | Pfizer | 2004-12-01 |
| Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin (NCT00932165) | Pfizer | 2004-12-01 |
| A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer (NCT00147485) | Pfizer | 2004-12-01 |
| A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery (NCT00644176) | Pfizer | 2004-11-01 |
| To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. (NCT00143338) | Pfizer | 2004-11-01 |
| Canadian Pegvisomant Compassionate Study In Acromegalic Patients (NCT00151437) | Pfizer | 2004-11-01 |
| An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. (NCT00138749) | Pfizer | 2004-11-01 |
| Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar (NCT00174226) | Pfizer | 2004-11-01 |
| Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. (NCT00137462) | Pfizer | 2004-11-01 |
| Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients (NCT00151476) | Pfizer | 2004-11-01 |
| Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) (NCT00087490) | Pfizer | 2004-10-01 |
| Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma (NCT00113529) | Pfizer | 2004-10-01 |
| Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis (NCT00938015) | Pfizer | 2004-10-01 |
| Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors (NCT00195260) | Pfizer | 2004-10-01 |
| Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) (NCT00084266) | Pfizer | 2004-10-01 |
| Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions (NCT00091689) | Pfizer | 2004-09-01 |
| A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer (NCT00141297) | Pfizer | 2004-09-01 |
| Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain (NCT00143169) | Pfizer | 2004-09-01 |
| A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 (NCT00094029) | Pfizer | 2004-09-01 |
| A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer (NCT00090701) | Pfizer | 2004-09-01 |
| Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer (NCT00094055) | Pfizer | 2004-09-01 |
| Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss (NCT00471172) | Pfizer | 2004-08-01 |
| SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma (NCT00083889) | Pfizer | 2004-08-01 |
| Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum (NCT00082563) | Pfizer | 2004-08-01 |
| Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation (NCT00219583) | Pfizer | 2004-08-01 |
| Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation (NCT00143117) | Pfizer | 2004-08-01 |
| Risk of Cancer Among Pantoprazole Users (NCT01322633) | Pfizer | 2004-07-01 |
| Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer (NCT00712504) | Pfizer | 2004-07-01 |
| A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections (NCT00360607) | Pfizer | 2004-07-01 |
| Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America (NCT00084227) | Pfizer | 2004-07-01 |
| Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) (NCT00150202) | Pfizer | 2004-07-01 |
| Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome (NCT00220402) | Pfizer | 2004-07-01 |
| Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. (NCT00174239) | Pfizer | 2004-07-01 |
| A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol (NCT00138762) | Pfizer | 2004-07-01 |
| A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease (NCT00134264) | Pfizer | 2004-07-01 |
| Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa (NCT00082576) | Pfizer | 2004-06-01 |
| Irinotecan Study For Cervical Cancer (NCT00136955) | Pfizer | 2004-06-01 |
| Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years (NCT00161785) | Pfizer | 2004-06-01 |
| A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain (NCT00660855) | Pfizer | 2004-06-01 |
| A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI (NCT00483028) | Pfizer | 2004-06-01 |
| Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee (NCT00652808) | Pfizer | 2004-05-01 |
| Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg (NCT00195338) | Pfizer | 2004-05-01 |